JC Decaux

Modelling (again) the impact of COVID-19

26/03/20 -"We have revised our forecasts downwards again, after the group indicated its Q1 guidance (-10% organic) is no longer valid and that Q2 will be worse, with the COVID-19 crisis spreading in Europe and ..."

PDF page sample
Pages
53
Language
English
Published on
26/03/20
Download
You may also be interested by these reports :
22/10/26
Pearson delivered accelerated Q3 sales growth but downgraded its guidance for FY26 at the divisional level. The performance was driven by all ...
22/10/26
RELX released 9M figures in line with underlying revenue growth of 7% at the group level, unchanged compared to H1 2026, as well as an unchanged ...
22/10/26
Total Group revenues, including MultiChoice, decreased by 1% yoy and lfl in Q3. This decline is disappointing, given stable revenues in H1 and slight ...
20/10/26
Since our last Teaser in December 2024, Publicis’(REDUCE, 7% UPSIDE) share price (France, Reduce) has gone through two distinct phases. A prolonged ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO